financetom
Business
financetom
/
Business
/
Snowflake Stock Is Falling Thursday: What's Driving The Action?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Snowflake Stock Is Falling Thursday: What's Driving The Action?
Aug 22, 2024 8:02 AM

Snowflake Inc ( SNOW ) shares are trading higher Thursday on the heels of the company’s second-quarter financial results. Several analysts also lowered price targets on the stock following the print.

Q2 Revenue: $868.823 million, versus estimates of $849.704 million

Q2 EPS: 18 cents, versus estimates of 16 cents

Total revenue was up 29% on a year-over-year basis, while product revenue totaled $829.3 million, up 30% year-over-year. Net revenue retention rate was 127% in the second quarter.

Remaining performance obligations came in at $5.2 billion, up 48% year-over-year. Snowflake noted that it ended the quarter with 510 customers, trailing 12-month product revenue surpassing $1 million.

The company’s board also authorized an additional $2.5 billion for its share repurchase program and extended the duration through March 2027. The company said it had $491.9 million remaining on its buyback as of July 31.

"The quarter was hallmarked by innovation and product delivery, and great traction in the early stages of our new AI products. With the combination of our platform, the network effect of collaboration and our AI innovations, we have a huge opportunity ahead to deliver even greater value to our customers," said Sridhar Ramaswamy, CEO of Snowflake.

Outlook: Snowflake sees third-quarter product revenue in the range of $850 million to $855 million, up approximately 22% on a year-over-year basis. 

The company also raised its full-year product revenue expectations. Snowflake now expects full-year product revenue of $3.356 billion, up 26% year-over-year.

See Also: Paramount Shares Jump In Pre-Market After Media Tycoon Edgar Bronfman Reportedly Sweetens Bid To $6B

Analyst Changes:

Baird maintained Snowflake with an Outperform and lowered its price target from $165 to $152.

Needham maintained Snowflake with a Buy and lowered its price target from $210 to $160.

JMP Securities maintained Snowflake with a Market Outperform and lowered its price target from $235 to $190.

SNOW Price Action: Snowflake shares were down 9.55% at $122.22 at the time of writing, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Karooooo Terminates Secondary Public Offering Due to Market Conditions
Karooooo Terminates Secondary Public Offering Due to Market Conditions
Jul 26, 2024
05:18 AM EDT, 07/26/2024 (MT Newswires) -- Karooooo ( KARO ) said Friday Chief Executive Isaias Jose Calisto has terminated the secondary public offering of ordinary shares, first announced on July 24. The company said despite strong investor interest and oversubscription, Calisto decided to halt the offering due to recent market changes affecting the share price. As a result of...
German truckmaker Traton posts profit rise on higher prices
German truckmaker Traton posts profit rise on higher prices
Jul 26, 2024
(Reuters) - German truckmaker Traton, majority-owned by Volkswagen, on Friday posted a 7% rise in first-half operating profit buoyed by higher prices, even as demand remained lacklustre in Europe. Operating profit rose to 2.1 billion euros ($2.3 billion) on sales revenue up 2% to 23.4 billion euros, while unit sales fell 5%. Traton's operating margin rose to 9.1% from 8.6%...
Heritage Commerce's Board Approves $15 Million Share Repurchase Program
Heritage Commerce's Board Approves $15 Million Share Repurchase Program
Jul 26, 2024
05:23 AM EDT, 07/26/2024 (MT Newswires) -- Heritage Commerce ( HTBK ) said late Thursday its board has approved a $15 million share repurchase program. The program is set to expire on July 31, 2025, unless suspended or terminated earlier. Price: 10.63, Change: -0.08, Percent Change: -0.75 ...
AbbVie Gets European Commission Marketing Authorization for Skyrizi to Treat Ulcerative Colitis
AbbVie Gets European Commission Marketing Authorization for Skyrizi to Treat Ulcerative Colitis
Jul 26, 2024
05:23 AM EDT, 07/26/2024 (MT Newswires) -- AbbVie ( ABBV ) said Friday the European Commission has approved Skyrizi for treating adult patients with moderately to severely active ulcerative colitis, a chronic inflammatory bowel disease. The marketing authorization for Skyrizi marks its fourth approved indication in the European Union, the company said. The medication is for patients who have had...
Copyright 2023-2026 - www.financetom.com All Rights Reserved